⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5530808 | 0.70 | — | — | |
| SCHEMBL2774259 | 0.61 | — | — | |
| SCHEMBL14726702 | 0.57 | — | — | |
| SCHEMBL7886075 | 0.53 | — | — | |
| SCHEMBL252133 | 0.50 | — | — | |
| SCHEMBL242393 | 0.50 | — | — | |
| SCHEMBL9807106 | 0.50 | — | — | |
| SCHEMBL6702792 | 0.50 | — | — | |
| SCHEMBL21494151 | 0.50 | — | — | |
| SCHEMBL9622643 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2688975-A1 | METHODS OF FLUID LOSS CONTROL AND FLUID DIVERSION IN SUBTERRANEAN FORMATIONS | Halliburton Energy Services, Inc. (US) | 2014-01-29 | — | — | EP | disclosed |
| US-8329924-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED (CA) | 2012-12-11 | — | — | US | disclosed |
| WO-2012127191-A1 | METHODS OF FLUID LOSS CONTROL AND FLUID DIVERSION IN SUBTERRANEAN FORMATIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| EP-2416806-A1 | FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2012-02-15 | — | — | EP | disclosed |
| EP-2323636-A1 | CHELATING AMPHIPHILIC POLYMERS | Koninklijke Philips Electronics N.V. (NL) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010116209-A1 | FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010029500-A1 | CHELATING AMPHIPHILIC POLYMERS | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2010-03-18 | — | — | WO | disclosed |
| EP-1809338-A4 | METHOD FOR CONTINUOUS VISUALIZATION OF A BLOOD CLOT OR PLAQUE IN A BODY LUMEN | FISHER JOHN S (US) | 2008-03-12 | — | — | EP | disclosed |
| EP-1809338-A1 | METHOD FOR CONTINUOUS VISUALIZATION OF A BLOOD CLOT OR PLAQUE IN A BODY LUMEN | Fisher, John S. (US) | 2007-07-25 | — | — | EP | disclosed |
| EP-1601383-A4 | METHOD FOR CONTINUOUS VISUALIZATION OF A BODY LUMEN | FISHER JOHN S (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2004080335-A2 | METHOD FOR CONTINUOUS VISUALIZATION OF A BODY LUMEN | FISHER JOHN STEELE (US) | 2004-09-23 | — | — | WO | disclosed |
| WO-2003033648-A2 | IMAGING THE ACTIVITY OF EXTRACELLULAR PROTEASES IN CELLS USING MUTANT ANTHRAX TOXIN PROTECTIVE ANTIGENS THAT ARE CLEAVED BY SPECIFIC EXTRACELLULAR PROTEASES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-04-24 | — | — | WO | disclosed |
| EP-0716358-B1 | Improved migration imaging members | XEROX CORP (US) | 1999-09-22 | — | — | EP | disclosed |
| US-5759701-A | INK JET PRINTING | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5635322-A | Process for developing and overcoating migration imaging members | XEROX CORPORTION (US) | 1997-06-03 | — | — | US | disclosed |
| US-5580689-A | SOLFTENABLE LAYER OF SOFTENABLE MATERIAL, PIGMENT SENSITIVE TO INFRARED OR RED LIGHT ILLUMINATION, AND MIGRATION MARKING MATERIAL | XEROX CORPORATION (US) | 1996-12-03 | — | — | US | disclosed |
| US-5534374-A | Migration imaging members | XEROX CORPORATION (US) | 1996-07-09 | — | — | US | disclosed |
| EP-0716358-A2 | Improved migration imaging members | XEROX CORPORATION (US) | 1996-06-12 | — | — | EP | disclosed |
| EP-0673781-A1 | Recording sheets containing amine salts and quaternary choline halides | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |
| WO-1995016470-A1 | A COMBINATION CAPABLE OF FORMING AN ODOUR BARRIER AND METHODS OF USE | HADDON BRUCE ALEXANDER (AU) | 1995-06-22 | — | — | WO | disclosed |